Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Phillips Precision, Inc.
483
•Phillips Precision, Inc.•July 17, 2024

FDA 483 - Phillips Precision, Inc. - July 17, 2024

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Phillips Precision, Inc.
Record Details

An FDA inspection of Phillips Precision, Inc., a contract manufacturer, conducted from April 22 to July 17, 2024, revealed significant deficiencies in its Quality System, particularly regarding cleaning processes for implantable devices and surgical instruments, and its corrective and preventive action (CAPA) system. The main violations centered on inadequate validation of critical cleaning processes. Phillips Precision failed to conduct comprehensive risk assessments, perform essential testing like cytotoxicity and endotoxin, and adequately challenge worst-case manufacturing conditions or load configurations. Unvalidated supplementary cleaning methods and insufficient sampling plans further compounded these issues. Monitoring and control of validated process parameters were also deficient. The company lacked procedures for load weight monitoring, experienced insufficient temperature controls, and failed to address out-of-specification start-up temperatures, which affected thousands of devices, including implants, without proper nonconformance reporting. Preventive maintenance for detergent concentration was less frequent than recommended by equipment specifications. Phillips Precision's CAPA system proved inadequate in effectively identifying and addressing root causes of nonconforming products. Investigations into issues like product staining and metal debris were found to be incomplete, failing to trend nonconformances across product lines, consider all potential causes (e.g., cleaning machine revalidation), or verify corrective actions over sufficient periods. The CAPA threshold system itself was also deemed flawed, not adequately considering risk or in-process nonconformances. Operating under the medical device Good Manufacturing Practices (21 CFR Part 820), Phillips Precision is required to implement comprehensive corrective actions. This involves revalidating deficient processes, establishing rigorous monitoring and control procedures, enhancing the CAPA system for thorough investigation and effective verification, and ensuring all quality system procedures meet regulatory standards to safeguard product safety and quality.

Company
Phillips Precision, Inc.
Inspection Date
July 17, 2024
Product Type
Devices
Office
New Jersey District Office
People
  • Jonathan Brealey
  • Shelby N. Turner
  • Jonathan Ho
  • Naakesh N. Gomanie
Open in Dashboard

ID · 98f7e82a-673d-409e-892d-9c7338d82fbd

KeyPedia
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.